Osteopontin
Top Cited Papers
Open Access
- 1 November 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (11) , 2302-2309
- https://doi.org/10.1161/atvbaha.107.144824
Abstract
Osteopontin (OPN) is a multifunctional molecule highly expressed in chronic inflammatory and autoimmune diseases, and it is specifically localized in and around inflammatory cells. OPN is a secreted adhesive molecule, and it is thought to aid in the recruitment of monocytes-macrophages and to regulate cytokine production in macrophages, dendritic cells, and T-cells. OPN has been classified as T-helper 1 cytokine and thus believed to exacerbate inflammation in several chronic inflammatory diseases, including atherosclerosis. Besides proinflammatory functions, physiologically OPN is a potent inhibitor of mineralization, it prevents ectopic calcium deposits and is a potent inducible inhibitor of vascular calcification. Clinically, OPN plasma levels have been found associated with various inflammatory diseases, including cardiovascular burden. It is thus imperative to dissect the OPN proinflammatory and anticalcific functions. OPN recruitment functions of inflammatory cells are thought to be mediated through its adhesive domains, especially the arginine-glycine-aspartate (RGD) sequence that interacts with several integrin heterodimers. However, the integrin receptors and intracellular pathways mediating OPN effects on immune cells are not well established. Furthermore, several studies show that OPN is cleaved by at least 2 classes of proteases: thrombin and matrix-metalloproteases (MMPs). Most importantly, at least in vitro, fragments generated by cleavage not only maintain OPN adhesive functions but also expose new active domains that may impart new activities. The role for OPN proteolytic fragments in vivo is almost completely unexplored. We believe that further knowledge of the effects of OPN fragments on cell responses might help in designing therapeutics targeting inflammatory and cardiovascular diseases.Keywords
This publication has 88 references indexed in Scilit:
- Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragmentsMatrix Biology, 2004
- Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient miceCellular Immunology, 2004
- Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in OsteoclastsPublished by Elsevier ,2003
- Resistance to Unloading-Induced Three-Dimensional Bone Loss in Osteopontin-Deficient MiceJournal of Bone and Mineral Research, 2002
- Structural elements of the osteopontin SVVYGLR motif important for the interaction with α4 integrinsFEBS Letters, 2001
- Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 IntegrinPublished by Elsevier ,1996
- The Human Integrin α8β1 Functions as a Receptor for Tenascin, Fibronectin, and VitronectinPublished by Elsevier ,1995
- Interaction of Osteopontin with Fibronectin and Other Extracellular Matrix MoleculesaAnnals of the New York Academy of Sciences, 1995
- The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.Journal of Clinical Investigation, 1995
- Osteopontin expression in angiotensin II-induced tubulointerstitial nephritisKidney International, 1994